Hudson Bay Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,000
Closed -$1.17M 672
2020
Q3
$1.17M Buy
20,000
+6,667
+50% +$494K 0.02% 409
2020
Q2
$1.49M Sell
13,333
-1,667
-11% -$119K 0.03% 342
2020
Q1
$1.01M Buy
15,000
+1,667
+13% +$168K 0.03% 328
2019
Q4
$1.84M Buy
+13,333
New +$1.73M 0.04% 291

Other funds holding OPTN

Hudson Bay Capital Management's OPTN Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 20,000 shares — an estimated $1.17M sold.

Hudson Bay Capital Management first reported a position in OPTN in Q4 2019 and held it in 4 quarters. The position peaked at $1.84M in Q4 2019. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 20,000 OptiNose shares in Q4 2020, an estimated $1.17M.
  • Hudson Bay Capital Management first reported a position in OptiNose in Q4 2019 and held it in 4 quarters.
  • Hudson Bay Capital Management's OptiNose position peaked at $1.84M in Q4 2019.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.